SG11202102149SA - Methods of treating mycobacterial infections using tetracycline compounds - Google Patents
Methods of treating mycobacterial infections using tetracycline compoundsInfo
- Publication number
- SG11202102149SA SG11202102149SA SG11202102149SA SG11202102149SA SG11202102149SA SG 11202102149S A SG11202102149S A SG 11202102149SA SG 11202102149S A SG11202102149S A SG 11202102149SA SG 11202102149S A SG11202102149S A SG 11202102149SA SG 11202102149S A SG11202102149S A SG 11202102149SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- tetracycline compounds
- mycobacterial infections
- treating mycobacterial
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726738P | 2018-09-04 | 2018-09-04 | |
| US201862731410P | 2018-09-14 | 2018-09-14 | |
| US201862746039P | 2018-10-16 | 2018-10-16 | |
| US201862760131P | 2018-11-13 | 2018-11-13 | |
| PCT/US2019/049368 WO2020051151A1 (en) | 2018-09-04 | 2019-09-03 | Methods of treating mycobacterial infections using tetracycline compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102149SA true SG11202102149SA (en) | 2021-04-29 |
Family
ID=69722600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102149SA SG11202102149SA (en) | 2018-09-04 | 2019-09-03 | Methods of treating mycobacterial infections using tetracycline compounds |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210346408A1 (en) |
| EP (1) | EP3846805A4 (en) |
| JP (1) | JP7466544B2 (en) |
| KR (1) | KR20210090160A (en) |
| CN (1) | CN113164456A (en) |
| AU (1) | AU2019335203A1 (en) |
| BR (1) | BR112021004057A2 (en) |
| CA (1) | CA3111447A1 (en) |
| MA (1) | MA53564A (en) |
| MX (1) | MX2021002503A (en) |
| PH (1) | PH12021550452A1 (en) |
| SG (1) | SG11202102149SA (en) |
| WO (1) | WO2020051151A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021288202A1 (en) * | 2020-06-11 | 2022-12-08 | Paratek Pharmaceuticals Inc. | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof |
| WO2022119899A1 (en) * | 2020-12-02 | 2022-06-09 | Shionogi & Co., Ltd. | A medicament for treating mycobacterial infection characterized by combining a cytochrome bc1 inhibitor with clarithromycin or azithromycin |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1301467T1 (en) * | 2000-07-07 | 2007-02-28 | Tufts College | 9-substituted minocycline compounds |
| US20060194773A1 (en) * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
| PT2271348T (en) * | 2008-03-28 | 2018-04-16 | Paratek Pharm Innc | Oral tablet formulation of tetracycline compound |
| SG11201808246SA (en) * | 2016-03-24 | 2018-10-30 | Paratek Pharm Innc | Methods for treating and preventing c. difficile infection |
| CN109414445A (en) * | 2016-05-02 | 2019-03-01 | 帕拉特克药品公司 | 9- Aminomethyl Minocycline compound and its application method in urethral infection (UTI) treatment |
| TWI746610B (en) * | 2016-08-03 | 2021-11-21 | 美商派瑞泰Ｓｐｖ２有限公司 | 9-aminomethyl minocycline compounds and uses thereof |
| GB201615693D0 (en) * | 2016-09-15 | 2016-11-02 | Combinatorx Infection Ltd | Combinations |
-
2019
- 2019-09-03 AU AU2019335203A patent/AU2019335203A1/en active Pending
- 2019-09-03 BR BR112021004057-9A patent/BR112021004057A2/en unknown
- 2019-09-03 SG SG11202102149SA patent/SG11202102149SA/en unknown
- 2019-09-03 JP JP2021536672A patent/JP7466544B2/en active Active
- 2019-09-03 WO PCT/US2019/049368 patent/WO2020051151A1/en active Application Filing
- 2019-09-03 CA CA3111447A patent/CA3111447A1/en active Pending
- 2019-09-03 US US17/273,034 patent/US20210346408A1/en active Pending
- 2019-09-03 MA MA053564A patent/MA53564A/en unknown
- 2019-09-03 EP EP19858573.9A patent/EP3846805A4/en active Pending
- 2019-09-03 CN CN201980072989.8A patent/CN113164456A/en active Pending
- 2019-09-03 MX MX2021002503A patent/MX2021002503A/en unknown
- 2019-09-03 KR KR1020217009806A patent/KR20210090160A/en unknown
-
2021
- 2021-03-03 PH PH12021550452A patent/PH12021550452A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112021004057A2 (en) | 2021-05-25 |
| AU2019335203A1 (en) | 2021-05-06 |
| JP7466544B2 (en) | 2024-04-12 |
| EP3846805A4 (en) | 2022-08-24 |
| JP2021536504A (en) | 2021-12-27 |
| MA53564A (en) | 2021-07-14 |
| CA3111447A1 (en) | 2020-03-12 |
| US20210346408A1 (en) | 2021-11-11 |
| CN113164456A (en) | 2021-07-23 |
| MX2021002503A (en) | 2021-06-15 |
| KR20210090160A (en) | 2021-07-19 |
| EP3846805A1 (en) | 2021-07-14 |
| PH12021550452A1 (en) | 2021-12-06 |
| WO2020051151A1 (en) | 2020-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10202101986UA (en) | Tetracycline compounds and methods of treatment | |
| HK1249432A1 (en) | Methods of treating bacterial infections | |
| IL271863B (en) | Compounds and use thereof for the treatment of microbial infections | |
| EP3383857A4 (en) | Compounds and methods of treating bacterial infections | |
| PL3384915T3 (en) | Carrimycin for the treatment of mycobacterium tuberculosis infections | |
| IL265830A (en) | Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same | |
| IL291266A (en) | Compositions and methods for treating infections | |
| EP3426671A4 (en) | Compounds and compositions for the treatment of infections | |
| SG11202102149SA (en) | Methods of treating mycobacterial infections using tetracycline compounds | |
| DK3630111T3 (en) | Compounds and methods for treating bacterial infections | |
| IL281775A (en) | Methods of treatment of infections using bacteria | |
| EP3618826C0 (en) | Compositions for the treatment of pathogenic infections | |
| ZA202006569B (en) | Methods of treating fungal infections | |
| EP3661496A4 (en) | Treatment of staphylococcal and enterococcal infections using substituted nitrostyrene compounds | |
| EP3565551A4 (en) | Methods of treating bacterial infections | |
| IL281140A (en) | Compounds and methods for treating fungal infections | |
| IL269681A (en) | New methods for the treatment of multiple sclerosis | |
| SG11202105877YA (en) | Method of treatment | |
| SG11202003009QA (en) | Methods of treating bacterial infections | |
| EP3472155A4 (en) | Deuterated compounds for treating pain | |
| SG11201710199PA (en) | Methods of treating multiple sclerosis | |
| ZA201901948B (en) | Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections | |
| IL277773A (en) | Compositions and methods for the treatment of ischemia and cardiomyopathy | |
| LT3781172T (en) | Treatment of pneumonia | |
| GB201820236D0 (en) | Method of treatment |